%0 Journal Article
%A Watts, Eleanor L
%A Perez-Cornago, Aurora
%A Fensom, Georgina K
%A Smith-Byrne, Karl
%A Noor, Urwah
%A Andrews, Colm D
%A Gunter, Marc J
%A Holmes, Michael V
%A Martin, Richard M
%A Tsilidis, Konstantinos K
%A Albanes, Demetrius
%A Barricarte, Aurelio
%A Bueno-de-Mesquita, H Bas
%A Cohn, Barbara A
%A Deschasaux-Tanguy, Melanie
%A Dimou, Niki L
%A Ferrucci, Luigi
%A Flicker, Leon
%A Freedman, Neal D
%A Giles, Graham G
%A Giovannucci, Edward L
%A Haiman, Christopher A
%A Hankey, Graham J
%A Holly, Jeffrey M P
%A Huang, Jiaqi
%A Huang, Wen-Yi
%A Hurwitz, Lauren M
%A Kaaks, Rudolf
%A Kubo, Tatsuhiko
%A Le Marchand, Loic
%A MacInnis, Robert J
%A Männistö, Satu
%A Metter, E Jeffrey
%A Mikami, Kazuya
%A Mucci, Lorelei A
%A Olsen, Anja W
%A Ozasa, Kotaro
%A Palli, Domenico
%A Penney, Kathryn L
%A Platz, Elizabeth A
%A Pollak, Michael N
%A Roobol, Monique J
%A Schaefer, Catherine A
%A Schenk, Jeannette M
%A Stattin, Pär
%A Tamakoshi, Akiko
%A Thysell, Elin
%A Tsai, Chiaojung Jillian
%A Touvier, Mathilde
%A Van Den Eeden, Stephen K
%A Weiderpass, Elisabete
%A Weinstein, Stephanie J
%A Wilkens, Lynne R
%A Yeap, Bu B
%A Allen, Naomi E
%A Key, Timothy J
%A Travis, Ruth C
%A Eeles, Rosalind A
%A Haiman, Christopher A
%A Kote-Jarai, Zsofia
%A Schumacher, Fredrick R
%A Benlloch, Sara
%A Olama, Ali Amin Al
%A Muir, Kenneth R
%A Berndt, Sonja I
%A Conti, David V
%A Wiklund, Fredrik
%A Chanock, Stephen
%A Wang, Ying
%A Tangen, Catherine M
%A Batra, Jyotsna
%A Clements, Judith A
%T Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.
%J International journal of epidemiology
%V 52
%N 1
%@ 0300-5771
%C Oxford
%I Oxford Univ. Press
%M DKFZ-2022-01319
%P 71-86
%D 2023
%Z 2023 Feb 8;52(1):71-86
%X Previous studies had limited power to assess the associations of circulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with clinically relevant prostate cancer as a primary endpoint, and the association of genetically predicted IGF-I with aggressive prostate cancer is not known. We aimed to investigate the associations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 concentrations with overall, aggressive and early-onset prostate cancer.Prospective analysis of biomarkers using the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset (up to 20 studies, 17 009 prostate cancer cases, including 2332 aggressive cases). Odds ratios (OR) and 95
%K Insulin-like growth factor-I (Other)
%K Mendelian randomization (Other)
%K aggressive prostate cancer (Other)
%K international consortia (Other)
%K prospective analysis (Other)
%K prostate cancer (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:35726641
%R 10.1093/ije/dyac124
%U https://inrepo02.dkfz.de/record/180416